Heart failure patients get continued access to promising oral treatment
Disease control
ENROLLING_BY_INVITATION
This study offers continued access to an oral medication called levosimendan for people with pulmonary hypertension (high blood pressure in the lungs) and a type of heart failure where the heart pumps normally but is stiff. About 800 participants who completed a previous levosime…
Phase: PHASE3 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC